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Increased detection of Enterovirus 68 (EV68) among patients with acute respiratory 
infections was reported from different parts of the world in the late 2000s since its first 
detection from pediatric patients with lower respiratory infections in 1962. However, the 
underlying mechanisms for such increasing trend are still unknown.  
Therefore, in the study, I first aimed at studying the etiological significance and the 
molecular evolution of circulating EV68 strains in the Philippines. 
Nasopharyngeal swabs were collected from 5,240 patients with acute respiratory infections 
in the Philippines from June 2009 to December 2011. EV68 was detected by polymerase 
chain reaction (PCR) targeting for 5’ untranslated region (5’UTR), viral protein 1 (VP1), and 
VP4/VP2. Phylogenetic trees were generated using the obtained sequences. 
Of the 5,240 tested samples, 12 EV68 positive cases were detected between August and 
December in 2011 (detection rate, 0.23%). The detection rate was higher among inpatients 
than outpatients (p<0.0001). Among VP1 sequences detected from 7 patients in 2011, 5 in 
lineage 2 were diverged from those detected in the Philippines in 2008, however, 2 in lineage 
3 were not diverged from strains detected in the Philippines in 2008 but closely associated 
with strains detected in the United States. Combined with my previous report, EV68 
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occurrences were observed twice in the Philippines within the last four years. EV68 
detections might be occurring in cyclic patterns, and viruses might have been maintained in 
the community while some strains might have been newly introduced. 
In the study, I also tested serum samples collected from pneumonia patients whose 
nasopharyngeal specimens were positive for EV68. Out of total 28 nasopharyngeal sample 
positive pediatric patients, EV68 were detected in serum samples among 12 (43%) patients 
aged between 1 and 4 years. My results suggest that EV68 can cause viremia by which the 
virus may exhibit systemic manifestations.  
Additionally, I studied the antigenicity and receptor binding properties of EV68 detected in 
recent years in comparison to the prototype strain of EV68; Fermon strain. I first performed 
neutralization (NT) and hemagglutination inhibition (HI) tests using antisera generated for 
EV68 strains detected in recent years. I found that Fermon strain had lower HI and NT 
titers than EV68 strains detected in recent years. The HI and NT titers were also 
significantly different between strains of different genetic lineages among EV68 strains 
detected in recent years. I further studied receptor binding specificities of EV68 strains for 
sialyloligosaccharides using glycan array. In glycan array analysis, all tested EV68 strains 
showed affinity to α2-6 linked sialic acids (SAs) compared to α2-3 SAs. My study 
demonstrated that emergence of strains with different antigenicity is the possible 
mechanisms for the increased detections of EV68 in recent years. Additionally, I revealed 
that EV68 preferably binds to α2-6 SAs which suggested that EV68 might have affinity to 
upper respiratory tract. 
 
 
402

